There are 2949 resources available
884TiP - AtTEnd/ENGOT-en7: A multicenter phase III double-blind randomized controlled trial of atezolizumab in combination with paclitaxel and carboplatin in women with advanced/recurrent endometrial cancer
Presenter: Nicoletta Colombo
Session: E-Poster Display
Resources:
Abstract
894P - Diffuse large B-cell testicular lymphomas (DLBCL-TL): Survival outcomes over 20 years
Presenter: Gonçalo Nogueira-Costa
Session: E-Poster Display
Resources:
Abstract
895P - Phase I study results of the type II glycoengineered humanized anti-CD20 monoclonal antibody MIL62 in Chinese patients with relapsed/refractory CD20-positive B-cell non-Hodgkin’s lymphoma
Presenter: Yuan-Kai Shi
Session: E-Poster Display
Resources:
Abstract
896P - Analysis of DLBCL genetic databases using machine learning
Presenter: Silvia Sequero Lopez
Session: E-Poster Display
Resources:
Abstract
897P - Survival of adult Burkitt lymphoma patients treated with the NHL-BFM 90 protocol in a 10-year period in Slovenia
Presenter: Lucka Boltezar
Session: E-Poster Display
Resources:
Abstract
898P - T-cell lymphomas (TCL): Real-world experience analysis from cancer registry
Presenter: Marina Puchinskaya
Session: E-Poster Display
Resources:
Abstract
899P - Pharmacoeconomic assessment of subcutaneous retuximab formulation compared to intravenous retuximab in NHL and CLL patients: A single institution experience
Presenter: Sherif Ahmed Mohamed
Session: E-Poster Display
Resources:
Abstract
900P - The emerging treatment options of plasmablastic lymphoma: Analysis of 173 individual patients’ outcomes
Presenter: Nafie Makady
Session: E-Poster Display
Resources:
Abstract
901P - Matching-adjusted indirect comparisons (MAIC) of safety between single-agent belantamab mafodotin versus selinexor plus dexamethasone in relapsed/refractory multiple myeloma (RRMM)
Presenter: Attaya Suvannasankha
Session: E-Poster Display
Resources:
Abstract
902P - Quality of life and response to treatment with ixazomib-lenalidomide-dexamethasone (IRd) in patients with relapsed/refractory multiple myeloma (RRMM) in a real-world setting
Presenter: Tatiana Ionova
Session: E-Poster Display
Resources:
Abstract